In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of ONEOK, Inc.
(NYSE:OKE), ServiceNow, Inc. (NYSE:NOW), Mirati Therapeutics, Inc.
(NASDAQ:MRTX), ImmunoCellular Therapeutics, Ltd (NYSE:IMUC), United
Technologies Corporation (NYSE:UTX), and USG Corporation (NYSE:USG)
including updated fundamental summaries, consolidated fiscal
reporting, and fully-qualified certified analyst research.
Complimentary Access: Research
Reports
Full copies of recently published
reports are available to readers at the links below.
OKE DOWNLOAD:
http://Fundamental-Markets.com/register/?so=OKE
NOW DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NOW
MRTX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=MRTX
IMUC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=IMUC
UTX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=UTX
USG DOWNLOAD:
http://Fundamental-Markets.com/register/?so=USG
(You may have to copy and paste the link
into your browser and hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above,
examine ONEOK, Inc. (NYSE:OKE), ServiceNow, Inc. (NYSE:NOW),
Mirati Therapeutics, Inc. (NASDAQ:MRTX), ImmunoCellular
Therapeutics, Ltd (NYSE:IMUC), United Technologies Corporation
(NYSE:UTX), and USG Corporation (NYSE:USG) on a fundamental level
and outlines the overall demand for their products and services in
addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts
from the recently released reports are available to today’s readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 7, 2017. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All amounts in
millions (except per share amounts).
-----------------------------------------
ONEOK, INC. (OKE) REPORT
OVERVIEW
ONEOK's Recent Financial
Performance
For the three months ended September 30, 2017 vs
September 30, 2016, ONEOK reported revenue of $2,906.4 vs $2,357.9
(up 23.3%), diluted earnings per share $0.43 vs $0.43 (unchanged),
and dividends per share $0.745 vs $0.615 (up 21.1%). For the twelve
months ended December 31, 2016 vs December 31, 2015, ONEOK reported
revenue of $8,920.9 vs $7,763.2 (up 14.9%), diluted earnings per
share $1.66 vs $1.16 (up 43.1%), and dividends per share $2.46 vs
$2.43 (up 1.2%).
To read the full ONEOK, Inc. (OKE) report,
download it here:
http://Fundamental-Markets.com/register/?so=OKE
-----------------------------------------
SERVICENOW, INC. (NOW) REPORT
OVERVIEW
ServiceNow's Recent Financial
Performance
For the three months ended June 30, 2017 vs June
30, 2016, ServiceNow reported revenue of $471.7 vs $341.3 (up
38.2%) and diluted earnings per share -$0.33 vs -$0.30. For the
twelve months ended December 31, 2016 vs December 31, 2015,
ServiceNow reported revenue of $1,390.5 vs $1,005.5 (up 38.3%) and
diluted earnings per share -$2.75 vs -$1.27.
To read the full ServiceNow, Inc. (NOW) report,
download it here:
http://Fundamental-Markets.com/register/?so=NOW
-----------------------------------------
MIRATI THERAPEUTICS, INC. (MRTX) REPORT
OVERVIEW
Mirati Therapeutics' Recent Financial
Performance
For the three months ended September 30, 2017 vs
September 30, 2016, Mirati Therapeutics reported diluted earnings
per share -$0.65 vs -$0.97. For the twelve months ended December
31, 2016 vs December 31, 2015, Mirati Therapeutics reported diluted
earnings per share -$4.20 vs -$3.82.
To read the full Mirati Therapeutics, Inc.
(MRTX) report, download it here:
http://Fundamental-Markets.com/register/?so=MRTX
-----------------------------------------
IMMUNOCELLULAR THERAPEUTICS, LTD (IMUC)
REPORT OVERVIEW
ImmunoCellular's Recent Financial
Performance
For the three months ended June 30, 2017 vs June
30, 2016 ImmunoCellular reported diluted earnings per share -$1.02
vs -$2.30. For the twelve months ended December 31, 2016 vs
December 31, 2015, ImmunoCellular reported earnings per share of
-$7.89 vs -$5.87.
To read the full ImmunoCellular Therapeutics,
Ltd (IMUC) report, download it here:
http://Fundamental-Markets.com/register/?so=IMUC
-----------------------------------------
UNITED TECHNOLOGIES CORPORATION (UTX)
REPORT OVERVIEW
United Technologies' Recent Financial
Performance
For the three months ended September 30, 2017 vs
September 30, 2016 United Technologies reported revenue of $15,062
vs $14,354 (up 4.9%), diluted earnings per share $1.67 vs $1.78
(down 6.2%). For the twelve months ended December 31, 2016 vs
December 31, 2015 UTX reported revenue of $57,244 vs $56,098 (up
2.0%) and diluted earnings per share $6.12 vs. $8.61 (down
28.9%).
To read the full United Technologies Corporation
(UTX) report, download it here:
http://Fundamental-Markets.com/register/?so=UTX
-----------------------------------------
USG CORPORATION (USG) REPORT
OVERVIEW
USG's Recent Financial
Performance
For the three months ended September 30, 2017 vs
September 30, 2016, USG reported revenue of $795 vs $767 (up 3.7%),
diluted earnings per share $0.46 vs $0.42 (up 9.5%). For the twelve
months ended December 31, 2016 vs December 31, 2015 USG
reported revenue of $3,017 vs $2,913 (up 3.6%) and diluted earnings
per share $3.46 vs $6.73 (down 48.6%).
To read the full USG Corporation (USG) report,
download it here:
http://Fundamental-Markets.com/register/?so=USG
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world’s leading
brokerages for over a decade—and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets’ roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets’ oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets’ roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets’ Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
© 2017 Fundamental Markets. All Rights
Reserved. For republishing permissions, please contact a partner
network manager at
partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst®
are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are
registered trademarks owned by Financial Industry Regulatory
Authority, Inc.
ONEOK (NYSE:OKE)
Historical Stock Chart
From Mar 2024 to Apr 2024
ONEOK (NYSE:OKE)
Historical Stock Chart
From Apr 2023 to Apr 2024